Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 560 of 1,261
  1. US 10000477

    Dopamine D3 receptor antagonist compounds

    Indivior UK Limited · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  2. US 10000468

    Pyrazines as modulators of GPR6

    Takeda Pharmaceutical Company Limited · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  3. US 9999634

    Dissolution stability of calcium carbonate tablets

    TAKEDA AS · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  4. US 9999591

    Immunogenic composition against Campylobacter jejuni

    United States of America as represented by the Secretary of the Air Force · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  5. US 9999657

    Polymer-factor VIII moiety conjugates

    Nektar Therapeutics · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  6. US 9999650

    Peptide and peptidomimetic inhibitors

    RA PHARMACEUTICALS, INC. · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  7. US 9999639

    Cellular extracts

    REGENICS AS · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  8. US 9999369

    Laser-scribed ferrogel sensor with magnetic particles

    Regents of the University of Minnesota · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  9. US 9999647

    Method for obtaining a plant extract and associated compositions

    ETHNODYNE · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  10. US 9999613

    2H-chromene derivatives as analgesic agents

    OBSHESTVO S OGRANICHENNOI OTVETSVENNOSTJU “LEOFORS” · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  11. US 9994856

    Method for increasing the activity of a cystic fibrosis transmembrane conductance regulator protein

    ProQR Therapeutics II B.V. · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  12. US 9994600

    Prodrug compounds and uses therof

    Ligand Pharmaceuticals Incorporated · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  13. US 9994558

    Multicyclic compounds and methods of using same

    Karyopharm Therapeutics Inc. · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  14. US 9994542

    Prodrugs of urolithins and uses thereof

    Amazentis SA · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  15. US 9994566

    Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryl or heteroaryl, preparation method thereof and pharmaceutical use thereof

    Shenyang Sunshine Pharmaceutical Co., LTD · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  16. US 9994852

    Oligonucleotide compositions and uses thereof

    MIRAGEN THERAPEUTICS, INC. · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  17. US 9993660

    Method of using laser-induced optoacoustics for the treatment of drug-resistant microbial infections

    The United States of America as represented by the Secretary of Navy · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  18. US 9993553

    Methods and compositions for targeted release of molecules from nanoscale carriers

    The Regents of the University of California · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  19. US 9994527

    Modified amino acids

    Sutro Biopharma, Inc. · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  20. US 9993765

    Portable oxygen enrichment device and method of use

    SEPARATION DESIGN GROUP LLC · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  21. US 9994584

    Process of synthesizing 3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1] heptane-2-carboxylic acid

    Lixte Biotechnology, Inc. · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  22. US 9993642

    Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of locomotion

    The Regents of the University of California · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  23. US 9993529

    Stable formulations of a hyaluronan-degrading enzyme

    HALOZYME, INC. · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  24. US 9993503

    Methods for production of platelets from pluripotent stem cells and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.